Our results indicated that SOCS5/JAK2/STAT3 was involved in anti-leukemia process of leonurine and that SOCS5 may be a potential diagnostic marker and therapeutic target for CML. Here, STAT3 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.